VACCINE FORMULATION INSTITUTE LIMITEDActive
Key figures
Like most small UK companies, VACCINE FORMULATION INSTITUTE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 55,378 | 82,515 | 30,768 | 10,132 | — |
| Total assets | 86,810 | 82,879 | 82,976 | 12,582 | — |
| Total liabilities | 240,783 | 149,799 | 138,101 | 20,027 | 14,652 |
| Net assets / total equity | 52,027 | 139,080 | 150,875 | 198,555 | -14,652 |
| Average number of employees | 2 | 2 | 2 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: VACCINE FORMULATION INSTITUTE LIMITED
Company
VACCINE FORMULATION INSTITUTE LIMITED is a private company limited by guarantee registered with Companies House under company number 08229389. It was incorporated on 26 Sep 2012. Its status is active. The registered office is in Godalming (GU7). Its nature of business (SIC 2007) is specialists medical practice activities (86220).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were −£14,652, down 107.4% on the previous year. The company had an average of 2 employees. Figures are available for 6 financial years (2020–2025).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 10 Oct 2026.